Jacob Jacobsen

Company: Evecxia Therapeutics

Job title: Chief Executive Officer

Seminars:

Panel Discussion: Debating the Value of Animal Models in Screening New Drugs for Antidepressant, Anxiolytic, or Antipsychotic Efficacy 11:15 am

What role, if any, do animal models of psychiatric disorders play in drug discovery? What insights can we gain from the history of successfully developed treatments to inform their predictive value? What else can be done from a nonclinical standpoint to generate supportive data for moving new target compounds into the clinic? Should we still…Read more

day: Day One Track A AM

Enhancing the Selectivity, Sensitivity & Predictive Validity of Animal Models to Successfully Translate Novel Antidepressant, Antipsychotic & Anxiolytic Therapeutics 1:01 pm

With a pressing need for in vivo assays that more accurately predict the effects of antidepressants, antipsychotics and anxiolytics in humans, join this collaborative workshop to benchmark new strategies, from recreating exact phenotypes to optimizing dose selection, to bridge the translational gap. Highlights Include: Leveraging advancements in systems neuroscience: which animal behaviours are meaningful indicators…Read more

day: Workshop Day